Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set

被引:4
|
作者
Ganie, Mohd Ashraf [1 ,2 ]
Rashid, Aafia [2 ]
Baba, Mohammad Salem [1 ]
Zargar, Mohd Afzal [3 ]
Wani, Imtiyaz Ahmad [2 ]
Nisar, Sobia [4 ]
Wani, Ishfaq Ahmad [2 ]
Douhath, Syed [2 ]
Sriwastawa, Mukesh [5 ]
Geer, Mohd Ishaq [6 ]
Asrar, Mir Mohd [2 ]
Kutum, Rintu [7 ,8 ]
Hassan, Saqib [9 ]
Khan, Shahid [10 ]
Rafi, Wajid [11 ]
Bhat, Dil Afroz [12 ]
Showkat, Wasia [2 ]
Sahar, Tajali [2 ]
Choh, Naseer Ahmad [13 ]
Khurshid, Rabia [14 ]
Mudassar, Syed [12 ]
Shah, Zafar Amin [15 ]
Shabir, Iram
Sofi, Sanjeed Ahmad [13 ]
Gupta, Nandita [11 ]
Hafeez, Imran [16 ,17 ]
Sreenivas, Vishnubatla [18 ]
机构
[1] Sheri Kashmir Inst Med Sci, Dept Endocrinol, Srinagar, India
[2] Sheri Kashmir Inst Med Sci, Dept Clin Res, Srinagar, India
[3] Cent Univ Kashmir, Dept Life Sci, Ganderbal, India
[4] Govt Med Coll, Dept Med, Srinagar, India
[5] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY USA
[6] Univ Kashmir, Dept Pharmacol, Srinagar, India
[7] Ashoka Univ, Dept Comp Sci, Sonepath, India
[8] Ashoka Univ, Trivedi Sch Biosci, Dept Comp Sci, Sonepath, India
[9] Deemed Univ, Sathyabama Inst Sci & Technol, Sch Bio & Chem Engn, Dept Biotechnol, Chennai, India
[10] AIIMS New Delhi, Dept Lab Med, New Delhi, India
[11] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[12] Sheri Kashmir Inst Med Sci, Dept Clin Biochem, Srinagar, India
[13] Sheri Kashmir Inst Med Sci, Dept Radiodiag & Imaging, Srinagar, India
[14] Sheri Kashmir Inst Med Sci, Dept Obstet & Gynecol, Srinagar, India
[15] Sheri Kashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, India
[16] Iowa State Univ, Dept Biochem, Ames, IA USA
[17] Sheri Kashmir Inst Med Sci, Dept Cardiol, Srinagar, India
[18] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
India; metabolism; oligomenorrhoea; PCOS; phenotype; polymenorrhoea; Pre-PCOS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MENSTRUAL CYCLES; WOMEN; MORPHOLOGY; CRITERIA; SPIRONOLACTONE; ASSOCIATION; ADOLESCENTS; POPULATION;
D O I
10.1111/cen.14964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivePolycystic ovary syndrome (PCOS) is a complex disorder with diverse metabolic implications. Diagnosis typically relies on oligo-amenorrhoea (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM). However, the role of polymenorrhoea in PCOS remains understudied. Additionally, limited information exists regarding metabolic disturbances in women with partial PCOS phenotypes that do not meet diagnostic criteria. This extensive database aims to provide substantial evidence on the metabolic implications of polymenorrhoea and partial PCOS phenotypes.DesignProspective observational study.Patients and MeasurementsIn this single-centre study, 6463 women with PCOS-like characteristics and 3142 age-matched healthy women were included. The study compared clinical (anthropometry, modified Ferriman Gallwey [mFG] score), hormonal (serum testosterone), and metabolic (plasma glucose, serum lipids, insulin) characteristics between women diagnosed with PCOS, those with partial PCOS phenotypes, and the healthy control groupResultsIn all, 5174 women met Rotterdam criteria for PCOS diagnosis, while 737 were classified as Pre-PCOS, including HA (n = 538), OA (n = 121), or PCOM (n = 78). Common clinical features included oligomenorrhoea (75.5%), hirsutism (82.9%), obesity (27.2%), hypertension (1.6%), metabolic syndrome (19.6%), and diabetes mellitus (5.6%). Women diagnosed with PCOS, HA only, and OA only exhibited higher average body mass index, plasma glucose levels (both fasting and 2 h after the oral glucose tolerance test), and lipid fractions in comparison to those with PCOM and the healthy controls. However, indices of insulin resistance were similar among women with PCOS, HA, PCOM, and OA, albeit higher than in the healthy controls. The polymenorrhoea subgroup (5.9%) had lower BMI and serum testosterone, but similar mFG score, plasma glucose, insulin, and lipid levels as the oligomenorrhoea subgroup.ConclusionThe metabolic disturbances observed in Pre-PCOS women highlight the need to reassess diagnostic criteria. Including the polymenorrhoea subcategory in PCOS criteria is recommended due to similar metabolic dysfunctions as the oligomenorrhoea group.
引用
收藏
页码:566 / 578
页数:13
相关论文
共 50 条
  • [41] Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association
    Morgante, G.
    Cappelli, V.
    Di Sabatino, A.
    Massaro, M. G.
    De Leo, V.
    MINERVA GINECOLOGICA, 2015, 67 (05): : 457 - 463
  • [42] Is Apelin a New Biomarker in Patients With Polycystic Ovary Syndrome?
    Dravecka, Ingrid
    Figurova, Jana
    Lazurova, Ivica
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S635 - S641
  • [43] A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota
    Yurtdas, Gamze
    Akdevelioglu, Yasemin
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2020, 39 (04) : 371 - 382
  • [44] New adolescent polycystic ovary syndrome perspectives
    Alemzadeh, R.
    Kansra, A. R.
    MINERVA PEDIATRICA, 2011, 63 (01) : 35 - 47
  • [45] The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
    Mukherjee, Anirban Goutam
    Wanjari, Uddesh Ramesh
    Kannampuzha, Sandra
    Murali, Reshma
    Namachivayam, Arunraj
    Ganesan, Raja
    Dey, Abhijit
    Babu, Achsha
    Renu, Kaviyarasi
    Vellingiri, Balachandar
    Ramanathan, Gnanasambandan
    Doss, C. George Priya
    Elsherbiny, Nehal
    Elsherbini, Amira M.
    Alsamman, Alsamman M.
    Zayed, Hatem
    Gopalakrishnan, Abilash Valsala
    METABOLITES, 2023, 13 (01)
  • [46] The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study
    Hosseinpanah, Farhad
    Barzin, Maryam
    Tehrani, Fahimeh R.
    Azizi, Fereidoun
    CLINICAL ENDOCRINOLOGY, 2011, 75 (05) : 692 - 697
  • [47] Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment
    Amato, M. C.
    Guarnotta, V.
    Forti, D.
    Donatelli, M.
    Dolcimascolo, S.
    Giordano, C.
    HUMAN REPRODUCTION, 2013, 28 (07) : 1919 - 1928
  • [48] Comparing therapeutic effects of Metformin and Pioglitazone in Polycystic ovary syndrome (PCOS)
    Navali, Nazli
    Shokoufe, Leila Azhary
    Mallah, Fatemeh
    Bastani, Parvin
    Mashrabi, Omid
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2012, 28 (03) : 390 - 394
  • [49] Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
    Iervolino, Matteo
    Lepore, Elisa
    Forte, Gianpiero
    Lagana, Antonio Simone
    Buzzaccarini, Giovanni
    Unfer, Vittorio
    NUTRIENTS, 2021, 13 (05)
  • [50] MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A Review
    Dymanowska, Izabela
    Frankowska, Karolina
    Krawczyk, Agata Malgorzata
    Kociuba, Julia
    Gil-Kulik, Paulina
    Banaszewska, Beata
    Polak, Grzegorz
    MEDICAL SCIENCE MONITOR, 2024, 30